Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to agree to take part in the trial by giving their consent.
- People who are 18 years of age or older at the time they give consent.
- People who have a suspected or confirmed cancer diagnosis that a doctor has recommended investigating with a biopsy (a procedure to remove a small sample of tissue for testing).
- People who are newly diagnosed or have a suspected cancer and have not yet received any treatment for it, or people who have had previous cancer treatment and are due to have a biopsy before starting a new round of treatment.
Who may not be able to join:
- People who have a known autoimmune disease (where the immune system attacks the body), a history of organ transplant, or a long-term kidney or liver condition that would make them ineligible for a type of cancer treatment called immunotherapy.
- People whose immune systems are severely weakened — for example, those taking medications that suppress the immune system, people who are HIV-positive and on antiviral medications, or people who have had an organ transplant.
- People who are pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Predicting In-Vivo Clinical Response to Immune Checkpoint Inhibitors & Researching Mechanisms of Tumor Cutting and Imaging
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.